Diabetes Mellitus, Non-Insulin-Dependent
|
0.700 |
SusceptibilityMutation
|
disease |
CLINVAR |
|
|
|
DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1 (disorder)
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Colorectal Carcinoma
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
POLYCYSTIC OVARY SYNDROME, SUSCEPTIBILITY TO
|
0.100 |
SusceptibilityMutation
|
phenotype |
CLINVAR |
|
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.700 |
Biomarker
|
disease |
BEFREE |
Calpain 10 was recently identified as a susceptibility gene for type 2 diabetes, whereas calpain 9 appears to be a gastric cancer suppressor.
|
11516996 |
2001 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese.
|
11891023 |
2002 |
Gestational Diabetes
|
0.060 |
GeneticVariation
|
phenotype |
BEFREE |
Calpain-10 haplotype combination and association with gestational diabetes mellitus.
|
15172858 |
2004 |
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CAPN10 showed a significant deficit of variation in the haplotype class defined by the derived allele at SNP44, a polymorphism that is significantly associated with diabetes in meta-analysis studies.
|
15696418 |
2005 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
CAPN10 showed a significant deficit of variation in the haplotype class defined by the derived allele at SNP44, a polymorphism that is significantly associated with diabetes in meta-analysis studies.
|
15696418 |
2005 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.700 |
Biomarker
|
disease |
BEFREE |
Calpain-10 (CAPN10) was the first gene for type 2 diabetes identified by positional cloning, wherein a combination of haplotypes conferred increased risk of diabetes.
|
15793266 |
2005 |
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Calpain-10 (CAPN10) was the first gene for type 2 diabetes identified by positional cloning, wherein a combination of haplotypes conferred increased risk of diabetes.
|
15793266 |
2005 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Calpain-10 (CAPN10) was the first gene for type 2 diabetes identified by positional cloning, wherein a combination of haplotypes conferred increased risk of diabetes.
|
15793266 |
2005 |
Polycystic Ovary Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians.
|
17106059 |
2007 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Calpain-10 and calpain-3 and the diabetes ankyrin repeat protein (DARP) have all been linked to insulin resistance and type 2 diabetes.
|
17305703 |
2007 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Calpain-10 and calpain-3 and the diabetes ankyrin repeat protein (DARP) have all been linked to insulin resistance and type 2 diabetes.
|
17305703 |
2007 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.700 |
Biomarker
|
disease |
BEFREE |
Calpain-10 and calpain-3 and the diabetes ankyrin repeat protein (DARP) have all been linked to insulin resistance and type 2 diabetes.
|
17305703 |
2007 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CAPN10 mRNA splicing and decay is not affected by a SNP associated with susceptibility to type 2 diabetes.
|
17511963 |
2007 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Calpain-10 was first identified through a genome scan seeking to identify diabetes predisposition genes.
|
17560157 |
2007 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Calpain-10 was first identified through a genome scan seeking to identify diabetes predisposition genes.
|
17560157 |
2007 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Calpain-10 gene and protein expression in human skeletal muscle: effect of acute lipid-induced insulin resistance and type 2 diabetes.
|
18089694 |
2008 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
CAPN10 association with CIMT was replicated, further supporting its role as a common genetic determinant of diabetes and atherosclerosis in Hispanics.
|
19193380 |
2009 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
CAPN10 association with CIMT was replicated, further supporting its role as a common genetic determinant of diabetes and atherosclerosis in Hispanics.
|
19193380 |
2009 |
Arteriosclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
CAPN10 association with CIMT was replicated, further supporting its role as a common genetic determinant of diabetes and atherosclerosis in Hispanics.
|
19193380 |
2009 |
Atherosclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
CAPN10 association with CIMT was replicated, further supporting its role as a common genetic determinant of diabetes and atherosclerosis in Hispanics.
|
19193380 |
2009 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CAPN10 (rs3792267) was marginally associated with T2D with OR=1.5 (p=0.08) when considering the model GG vs. AG/AA with risk allele G. ENPP1 (rs1044498) was not associated with T2D.
|
19643578 |
2009 |